Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Noninvasive diagnostic criteria for hepatocellular carcinoma

Han Chu Lee

Clin Mol Hepatol. 2012;18(2):174-177. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.174

View: 6520 Download: 53 Crossref: 3

11

Special Contribution : Practice guidelines for management of hepatocellular carcinoma 2009

Korean Liver Cancer Study Group and National Cancer Center, Korea

Clin Mol Hepatol. 2009;15(3):391-423. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.391

View: 9393 Download: 106 Crossref: 206

3

A Clinical Study on Small Hepatocellular Carcinoma

Kyoung Soo Kim, M.D., Soon Ho Um, M.D., Ho Sang Ryu, M.D., Mi Ra Park , Jae Won Lee , Dong Gyu Park, M.D., Sung Joon Lee, M.D., Goo Lee, M.D., Kwang Hee Kim, M.D., Yoon Tae Jin, M.D., Hoon Jai Chun, M.D., Chi Wook Song, M.D., Sang Woo Lee, M.D., Jai Hyun Choi, M.D., Chang Duck Kim, M.D., Hyun Jin Hai, M.D., Yoon Hwan Kim, M.D. and Sung Ok Seo, M.D.

Clin Mol Hepatol. 1998;4(4):365-380. Published online January 1, 2000

View: 2199 Download: 13

1 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5413	MAFLD: How is it different from NAFLD?
Viewed By 5222	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5101	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search